Reviva Pharmaceuticals Holdings Inc — Quarterly Cash Flow (NASDAQ:RVPH) | MetaTrader

Open full chart

Financials

Overview 明細書 Statistics Dividends

Quarterly Annual

Total assets 7.63 M15.5 M7.08 M11.63 M14.33 M Total liabilities 17.61 M14.69 M11.54 M12.09 M9.78 M Total equity -9.98 M812.57 K-4.46 M-459.15 K4.55 M Total liabilities & shareholders' equities 7.63 M15.5 M7.08 M11.63 M14.33 M Total debt ————— Net debt —————

ニュース

Vocal biomarker study supports brilaroxazine’s efficacy in schizophrenia

Chardan Capital、Reviva Pharmaceuticals株に「買い」評価で調査開始

Chardan Capital assumes coverage on Reviva Pharmaceuticals stock with Buy rating

Vanguard Total Stock Market ETF (VTI) Daily Snapshot—12/30/25 - TipRanks.com

レビバ・ファーマシューティカルズの株式評価、H.C.ウェインライトがBuy評価を維持

Reviva Pharmaceuticals stock rating reiterated at Buy by H.C. Wainwright

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.16%

レビバ・ファーマシューティカルズの株価、FDAが第2相臨床試験を要求し急落

Reviva Pharmaceuticals stock plunges after FDA requests second Phase 3 trial

FDA、レビバの統合失調症治療薬に第2相の第3相試験を推奨

FDA recommends second phase 3 trial for Reviva’s schizophrenia drug

Dow Gains 100 Points; US Durable Goods Orders Decline In October - Argo Blockchain (NASDAQ:ARBK), Starfighters Space (AMEX:FJET)